Which is the Largest Market for Single Domain Antibody Platforms?Posted by sandeep gade on October 10th, 2022 The global Single Domain Antibody Platforms Market is likely to jump the innovation gun by reaching US$ 22 Mn by the year 2022. The CAGR would be 10%. With mental health being the prerogative, there is telepsychiatry in place. It has been a proven fact that physical ailments would get cured speedily if the psyche is in place. With geographical barriers getting transcended, telepsychiatry would be an indispensable part of the healthcare vertical. This would be the fact about the healthcare vertical in the future. Monoclonal antibodies are highly efficient as therapeutics against viral infections, immune diseases, and cancer. However, they are large in size and unable to access some epitopes, besides the production cost being high. Hence, single-domain antibodies (sdAbs) is an alternative for monoclonal due to larger number of accessible epitopes, smaller size, relatively low production costs, and potent inhibitors against immune and viral diseases. Currently, single-domain antibodies are being developed against a number of viruses, including influenza viruses, HIV, hepatitis C virus (HCV), enteric viruses, and respiratory syncytial virus (RSV). Technological advancements in single-domain antibody platforms such as production of bispecific and multi-specific antibodies to target particular antigens during therapeutic developments are some other factors that will boost the growth of the single-domain antibody platforms market. To remain ‘ahead’ of your competitors, request for free sample copy @ https://www.persistencemarketresearch.com/samples/28351 According to a latest report published by PMR, the global single-domain antibody platforms market is projected to be valued at US$ 22 Mn in 2020, and is expected to witness an impressive CAGR of around 10% during the forecast period (2020 – 2030). Key Takeaways from Single-Domain Antibody Platforms Market Study
“Rise in prevalence of infectious disease and demand for immunotherapy for preventive treatments will boost the global single-domain antibody platforms market,” says a PMR analyst. Get a Customized Scope to Match Your Need Ask an Expert- https://www.persistencemarketresearch.com/request-customization/28351 Collaborations & Acquisitions – Key Strategies amongst Market Players Leading players in the single-domain antibody platforms market are strengthening their product portfolios by launching new products.
What Does the Report Cover? Persistence Market Research offers a unique perspective and actionable insights on the single-domain antibody platforms market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of platform type (multi-specific single-domain antibody, bispecific single-domain antibody, multivalent single-domain antibody, and mono-specific single-domain antibody), animal source (camelids and sharks), application (diagnostic laboratories, therapeutic development, and research & development activities) and end user (diagnostic laboratories, clinical laboratories, academic and research institutes, and pharmaceutical and biotechnology companies), across seven key regions. For in-depth competitive analysis, buy now @ https://www.persistencemarketresearch.com/checkout/28351 About Us: –
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information. Contact us: Persistence Market Research Like it? Share it!More by this author |